Molecular Logic Gates and Switches
FULL PAPER
metal ion, respectively. Fluorescence quantum yields were measured
2-p-Tolyl-5-(pyridin-2-yl)-1,3,4-oxadiazole (1c): 1H NMR (500 MHz,
CDCl3, TMS): d=2.44 (s, 3H), 7.33 (d, J=8.0 Hz, 2H), 7.46 (t, J=
6.0 Hz, 1H), 7.89 (t, J=8.0 Hz, 1H), 8.10 (d, J=7.0 Hz, 2H), 8.31 (d, J=
8.0 Hz, 1H), 8.81 ppm (d, J=4.5 Hz, 1H); 13C NMR (100 MHz, CDCl3,
TMS): d=21.6, 120.8, 123.1, 125.7, 127.2, 129.7, 137.1, 142.6, 143.7, 150.2,
163.6, 165.7 ppm; HRMS (ESI): m/z: calcd for C14H12N3O: 238.0980
[M+H+]; found: 238.0983 [M+H+].
2-Phenyl-5-(pyridin-2-yl)-1,3,4-oxadiazole (1d): 1H NMR (500 MHz,
CDCl3, TMS): d=7.47–7.49 (m, 1H), 7.52–7.57 (m, 3H), 7.89–7.93 (m,
1H), 8.22–8.24 (m, 2H), 8.32 (d, J=8.0 Hz, 1H), 8.82–8.83 ppm (m, 1H);
13C NMR (100 MHz, CDCl3, TMS): d=123.3, 123.7, 125.8, 127.3, 129.0,
132.0, 137.2, 143.7, 150.3, 163.9, 165.6 ppm; HRMS (ESI): m/z: calcd for
C13H10N3O: 224.0824 [M+H+]; found: 224.0817 [M+H+].
using quinine sulfate as a standard (0.546 in 0.5m H2SO4).[10]
ꢀ
ꢁ
pffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
AlimitꢀA0
2c0
2
A ¼ A0 þ
cMþ1=Ksþc0ꢀ ðcMþ1=Ksþc0Þ ꢀ4c0cM
ð1Þ
1H NMR (500 MHz) and 13C NMR (100 MHz) spectra were recorded in
CDCl3 with TMS as an internal standard. 1H NMR (400 MHz) titrations
of 1d by Zn2+ and Hg2+ were carried out in CD3CN. HRMS spectra
were obtained by using methanol as the solvent.
Single-crystal X-ray diffraction data were collected at 273 K. Absorption
corrections were applied by using the multiscan program SADBS. The
structure was solved by direct methods, and non-hydrogen atoms were
refined anisotropically by a least-squares method on F2 by using the
SHELXTL-97 program. The hydrogen atoms were generated geometri-
cally (C–H, 0.96 ꢁ). CCDC-745239 (1b) contains the supplementary
crystallographic data for this paper. These data can be obtained free of
charge from The Cambridge Crystallographic Data Centre via
2-(4-Chlorophenyl)-5-(pyridin-2-yl)-1,3,4-oxadiazole
(1e):
1H NMR
(500 MHz, CDCl3, TMS): d=7.47–7.50 (m, 1H), 7.52 (d, 2H, J=9.0 Hz,
2H), 7.89–7.93 (m, 1H), 8.16 (d, J=8.5 Hz, 2H), 8.32 (d, J=7.5 Hz, 1H),
8.82 ppm (d, J=4.5 Hz, 1H); 13C NMR (100 MHz, CDCl3, TMS): d=
122.1, 123.3, 125.9, 128.5, 129.4, 137.2, 138.3, 143.5, 150.3, 164.0,
164.8 ppm; HRMS (ESI): m/z: calcd for C13H9ClN3O: 258.0434 [M+H+];
found: 258.0434 [M+H+].
1
Geometry optimizations and vibrational analysis were performed by den-
sity functional theory with Beckeꢂs three-parameter hybrid exchange
functional and the Lee–Yang–Parr correlation functional (B3LYP) imple-
mented in the Gaussian 03 package. The 6-31G* basis set was used in all
calculations.
2,5-Diphenyl-1,3,4-oxadiazole (2): H NMR (500 MHz, CDCl3, TMS): d=
7.52–7.57 (m, 6H), 8.14–8.16 ppm (m, 4H); 13C NMR (100 MHz, CDCl3,
TMS): d=123.9, 126.9, 129.1, 131.7, 164.6 ppm; HRMS (ESI): m/z: calcd
for C14H11N2O: 223.0871 [M+H+]; found: 223.0875 [M+H+].
2-Phenyl-5-(pyridin-2-yl)-1,3,4-thiadiazole (3): 1H NMR (500 MHz,
CDCl3, TMS): d=7.39–7.41 (m, 1H), 7.51–7.52 (m, 3H), 7.87 (t, J=
8.0 Hz, 1H), 8.05 (t, J=3.5 Hz, 2H), 8.40 (d, J=8.0 Hz, 1H), 8.68 ppm
(d, J=5.0 Hz, 1H); 13C NMR (100 MHz, CDCl3, TMS): d=121.0, 125.3,
128.0, 129.2, 130.3, 131.2, 137.2, 149.2, 149.8, 169.9, 170.0 ppm; HRMS
(ESI): m/z: calcd for C13H10N3S: 240.0595 [M+H+]; found: 240.0590
[M+H+].
Preparation and characterization of 1–3: The substituted benzoyl chlo-
ride (2.2 mmol) in CH2Cl2 (10 mL) was added dropwise to a dried round
flask containing picolinohydrazine or benzoyl hydrazine (2.0 mmol), pyri-
dine (1.0 mL), and N,N-dimethyl-4-aminopyridine (DMAP; 60 mg) in di-
chloromethane (15 mL). The mixture was stirred at room temperature
for 6 h and then washed with dilute aqueous HCl (1m, 3ꢃ10 mL) and
water (3ꢃ10 mL), and dried over sodium sulfate. After removal of the
solvent at reduced pressure, N’-(4-substituted-benzoyl)picolinohydrazide
or N’-benzoylbenzohydrazide was obtained as a white solid in 85% yield,
and was directly used for the next step.
1 and 2 were respectively synthesized from N’-(4-substituted-benzoyl)pi-
colinohydrazide and N’-benzoylbenzohydrazide (1.5 mmol) by heating its
POCl3 (10 mL) solution at reflux for 6 h. After cooling, the solution was
poured into iced water and neutralized with saturated NaHCO3 solution.
The resulting solution was extracted with CHCl3 (3ꢃ15 mL) and the or-
ganic phase was washed with water (3ꢃ15 mL) and saturated NaHCO3
solution (3ꢃ15 mL), and dried over sodium sulfate. After evaporation of
the solvent under reduced pressure, the residue was subjected to column
chromatography on silica gel (ethyl acetate/petroleum ether, 1:3) to
afford 1 or 2 in 75–80% yield.
Acknowledgements
This work was supported by the NSFC of China through grant nos.
J0630429, 20675069, and 20835005.
[1] V. Balzani, A. Credi, F. M. Raymo, J. F. Stoddart, Angew. Chem.
[2] a) J. Andrꢄasson, U. Pischel, Chem. Soc. Rev. 2010, 39, 174–188;
b) K. Szacilowski, Chem. Rev. 2008, 108, 3481–3548; c) U. Pischel,
Compound 3 was synthesized by heating the solution of N’-benzoylpicoli-
nohydrazide (1.5 mmol) and P2S5 (8 equiv) in pyridine (20 mL) to reflux.
After evaporation of the solvent under reduced pressure, water (30 mL)
was added and the mixture was extracted with CH2Cl2 (3ꢃ10 mL). The
CH2Cl2 phase was washed with KOH (1m, 3ꢃ10 mL) and then HCl (1m,
3ꢃ10 mL), and dried over sodium sulfate. The solvent was removed
under reduced pressure, and the crude product was purified by column
chromatography on silica gel (ethyl acetate/petroleum ether, 1:4) to
afford 3 as a white solid in 60% yield.
[4] For reviews, see: a) A. P. de Silva, T. P. Vance, M. E. S. West, G. D.
Dixon, H. Q. N. Gunaratne, T. Gunnlaugsson, P. R. S. Maxwell, T. E.
2-(4-Dimethylamino)-5-(pyridin-2-yl)-1,3,4-oxadiazole (1a): 1H NMR
(500 MHz, CDCl3, TMS): d=3.07 (s, 6H), 6.75 (d, J=9.0 Hz, 2H), 7.42–
7.45ACHTUNGTRENNUNG(m, 1H), 7.85–7.89 (m, 1H), 8.06 (d, J=9.0 Hz, 2H), 8.29 (d, J=
8.0 Hz, 1H), 8.79–8.81 ppm (m, 1H); 13C NMR (100 MHz, CDCl3, TMS):
d=40.0, 110.6, 111.5, 122.9, 125.3, 128.7, 137.0, 144.1, 150.1, 152.6, 162.8,
166.3 ppm; HRMS (ESI): m/z: calcd for C15H15N4O: 267.1246 [M+H+];
found: 267.1241 [M+H+].
2-(4-Ethoxyphenyl)-5-(pyridin-2-yl)-1,3,4-oxadiazole
(1b):
1H NMR
(500 MHz, CDCl3, TMS): d=1.46 (t, J=7.0 Hz, 3H), 4.12 (q, J=7.0 Hz,
2H), 7.01 (d, J=9.0 Hz, 2H), 7.45–7.47 (m, 1H), 7.88–7.91 (m, 1H), 8.14
(d, J=9.0 Hz, 2H), 8.30 (d, J=8.0 Hz, 1H), 8.80–8.82 ppm (m, 1H);
13C NMR (100 MHz, CDCl3, TMS): d=14.7, 63.8, 114.9, 115.9, 123.1,
125.6, 129.1, 137.1, 143.9, 150.2, 162.0, 163.4, 165.6 ppm; HRMS (ESI):
m/z: calcd for C15H14N3O2: 268.1086 [M+H+]; found: 268.1083 [M+H+].
[5] For some latest papers, see: a) P. Remꢅn, R. Ferreira, J. M. Monte-
negro, R. Suau, E. Pꢄrez-Inestrosa, U. Pischel, ChemPhysChem
2009, 10, 2004–2007; b) L. Mu, W. Shi, G. She, J. C. Chang, S. T.
Chem. Eur. J. 2010, 16, 5794 – 5802
ꢀ 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
5801